Evidence map›Paper›PMID 25730879›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2015

Rare variants in neuronal excitability genes influence risk for bipolar disorder.

Seth A Ament, Szabolcs Szelinger, Gustavo Glusman, Justin Ashworth, Liping Hou, Nirmala Akula, Tatyana Shekhtman, Judith A Badner, Mary E Brunkow, Denise E Mauldin and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed, 8 pooled it
19.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 8 syntheses or guidelines pooled it, 183 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Article
  10. Review
  11. Article
  12. Deletion of the Voltage-Gated Calcium Channel Gene, CaCerebellum (London, England) · 2025
    Article
  13. Article
  14. Article
  15. The Impact of Overexpression of the Mouse Ortholog ofBiological psychiatry global open science · 2025
    Article
  16. Proteostasis regulation of GABABiomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2025
    Review
  17. Review
  18. Article
  19. The L-type calcium channel CaV1.3: A potential target for cancer therapy.Journal of cellular and molecular medicine · 2024
    Review
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 9 institutions in 2 countries.

Seth A AmentInstitute for Systems Biology, Seattle, WA 98109;
Szabolcs SzelingerNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ 85004;
Gustavo GlusmanInstitute for Systems Biology, Seattle, WA 98109;
Justin AshworthInstitute for Systems Biology, Seattle, WA 98109;
Liping HouMood and Anxiety Disorders Section, Human Genetics Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD 20892;
Nirmala AkulaMood and Anxiety Disorders Section, Human Genetics Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD 20892;
Tatyana ShekhtmanDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093;
Judith A BadnerDepartment of Psychiatry, University of Chicago, Chicago, IL 60637;
Mary E BrunkowInstitute for Systems Biology, Seattle, WA 98109;
Denise E MauldinInstitute for Systems Biology, Seattle, WA 98109;
Anna-Barbara StittrichInstitute for Systems Biology, Seattle, WA 98109;
Katherine RouleauInstitute for Systems Biology, Seattle, WA 98109;
Sevilla D Detera-WadleighMood and Anxiety Disorders Section, Human Genetics Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD 20892;
John I NurnbergerDepartment of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202; Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202;
Howard J EdenbergDepartment of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indianapolis, IN 46202; and.ORCID http://orcid.org/0000-0003-0344-9690
Elliot S GershonDepartment of Psychiatry, University of Chicago, Chicago, IL 60637;
Nicholas SchorkJ. Craig Venter Institute, La Jolla, CA 92037.
Bipolar Genome Study
Nathan D PriceInstitute for Systems Biology, Seattle, WA 98109;
Richard GelinasInstitute for Systems Biology, Seattle, WA 98109;
Leroy HoodInstitute for Systems Biology, Seattle, WA 98109; lhood@systemsbiology.org mcmahonf@intra.nimh.nih.gov jkelsoe@ucsd.edu jroach@systemsbiology.org.
David CraigNeurogenomics Division, The Translational Genomics Research Institute, Phoenix, AZ 85004;
Francis J McMahonMood and Anxiety Disorders Section, Human Genetics Branch, National Institute of Mental Health Intramural Research Program, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD 20892; lhood@systemsbiology.org mcmahonf@intra.nimh.nih.gov jkelsoe@ucsd.edu jroach@systemsbiology.org.
John R KelsoeDepartment of Psychiatry, University of California, San Diego, La Jolla, CA 92093; lhood@systemsbiology.org mcmahonf@intra.nimh.nih.gov jkelsoe@ucsd.edu jroach@systemsbiology.org.
Jared C RoachInstitute for Systems Biology, Seattle, WA 98109; lhood@systemsbiology.org mcmahonf@intra.nimh.nih.gov jkelsoe@ucsd.edu jroach@systemsbiology.org.
Institute for Systems Biology · USTranslational Genomics Research Institute · USUnited States Department of Health and Human Services · USUniversity of Chicago · USIndiana University School of MedicineJ. Craig Venter Institute · USUniversity of California San Diego · USUniversity of California System · USNational Institutes of Health · US

Funding

Mapping genes that contribute to bipolar disorderZIAMH002810 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$31.2M
Quantitative Systems BiologyP50GM076547 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI BALIGA, NITIN S · 2006 to 2016
$30.6M
Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Identification of Genes Involved in Major Mood DisordersZIAMH002843 · NIMH · NATIONAL INSTITUTE OF MENTAL HEALTH · PI MCMAHON, FRANCIS J · 2009 to 2025
$24.5M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
The Collaborative Genetic Study of Nicotine DependenceP01CA089392 · NCI · WASHINGTON UNIVERSITY · PI BIERUT, LAURA J. · 2001 to 2012
$17.3M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH059534 · NIMH · WASHINGTON UNIVERSITY · PI RICE, JOHN P. · 1998 to 2007
$3.1M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH059545 · NIMH · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI NURNBERGER, JOHN I · 1998 to 2007
$2.6M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH059533 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MACKINNON, DEAN FREDERICK · 1998 to 2007
$2.4M
The Bipolar Genome StudyR01MH094483 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CRAIG, DAVID W, EDENBERG, HOWARD J · 2012 to 2014
$2.2M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH060068 · NIMH · UNIVERSITY OF CALIFORNIA IRVINE · PI BYERLEY, WILLIAM · 1998 to 2007
$2.1M
COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDERR01MH059553 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI BERRETTINI, WADE H · 1998 to 2007
$2.1M
Intramural NIH HHS Z01 MH002810NCATS NIH HHS UL1 TR001108NCI NIH HHS P01 CA089392NCI NIH HHS P50CA89392NIDA NIH HHS 5K02DA021237NIDA NIH HHS K02 DA021237NIGMS NIH HHS P50 GM076547NIMH NIH HHS 1Z01MH002810-01NIMH NIH HHS MH059534NIMH NIH HHS MH059548NIMH NIH HHS MH059556NIMH NIH HHS MH59533NIMH NIH HHS MH59535NIMH NIH HHS MH59545NIMH NIH HHS MH59553NIMH NIH HHS MH59567NIMH NIH HHS MH60068NIMH NIH HHS R01 MH059533NIMH NIH HHS R01 MH059534NIMH NIH HHS R01 MH059535NIMH NIH HHS R01 MH059545NIMH NIH HHS R01 MH059548NIMH NIH HHS R01 MH059553NIMH NIH HHS R01 MH059556NIMH NIH HHS R01 MH059567NIMH NIH HHS R01 MH060068NIMH NIH HHS R01 MH094483
6 · The paper itself

Abstract

We sequenced the genomes of 200 individuals from 41 families multiply affected with bipolar disorder (BD) to identify contributions of rare variants to genetic risk. We initially focused on 3,087 candidate genes with known synaptic functions or prior evidence from genome-wide association studies. BD pedigrees had an increased burden of rare variants in genes encoding neuronal ion channels, including subunits of GABAA receptors and voltage-gated calcium channels. Four uncommon coding and regulatory variants also showed significant association, including a missense variant in GABRA6. Targeted sequencing of 26 of these candidate genes in an additional 3,014 cases and 1,717 controls confirmed rare variant associations in ANK3, CACNA1B, CACNA1C, CACNA1D, CACNG2, CAMK2A, and NGF. Variants in promoters and 5' and 3' UTRs contributed more strongly than coding variants to risk for BD, both in pedigrees and in the case-control cohort. The genes and pathways identified in this study regulate diverse aspects of neuronal excitability. We conclude that rare variants in neuronal excitability genes contribute to risk for BD.

Indexed as

Genetic Predisposition to DiseaseGenetic VariationBipolar DisorderCase-Control StudiesFemaleGenetic Association StudiesHumansMaleNeuronsPedigreePolymorphism, Single NucleotideRisk FactorsSignal TransductionWhite Peoplebipolar disorderfamily genomicsGABAA receptorregulatory variantsvoltage-gated calcium channel

Identifiers

PMID25730879
PMCPMC4371952
OpenAlexW2041915741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.